TRANEXAM Labatec sol inj 500 mg/5ml amp 5 pce
7680693900011
CH-69390
B02AA02
06.06.0.
1 / 3
google
Details
- Product number
- 6939001
- CPT
- -
- Packaging group
- 5
- Unit
- Ampulle(n)
- Composition
- acidum tranexamicum 500 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium max. 0.38 mg.
Articles (1)
Tranexam Labatec 500 mg/5 mL, solution injectable
Injektionslösung
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 69390
- Drug name
- Tranexam Labatec, solution injectable
- Galenic form
- LSINJ
- ATC Code
- B02AA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/08/2024
- Authorization expiration date
- 27/08/2029
- IT number
- 06.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRANEXAM Labatec sol inj 500 mg/5ml amp 5 pce
- Description (DE)
- TRANEXAM Labatec Inj Lös 500 mg/5ml Amp 5 Stk
- Market launch
- 28/08/2024
- Narcotic (BTM)
- No